AP News

News Summary: Targeted cancer drug approved


SMART BOMB DRUG: Federal health regulators approved an innovative breast cancer drug on Friday that targets tumor cells while sparing healthy ones.

PHARMA COCKTAIL: The drug Kadcyla from Roche combines the older drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together.

TUMOR TARGETING: The binding chemical keeps the cocktail intact until it hits a cancer cell, delivering a potent dose of anti-tumor poison.


China's Killer Profits
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus